The role of genetic factors in the development of hyperhomocysteinemia

被引:31
作者
Geisel, J [1 ]
Hübner, U [1 ]
Bodis, M [1 ]
Schorr, H [1 ]
Knapp, JP [1 ]
Obeid, R [1 ]
Herrmann, W [1 ]
机构
[1] Saarland Med Sch, Dept Clin Chem, D-66421 Homburg, Germany
关键词
genetics; homocysteine; polymorphism; vegetarians;
D O I
10.1515/CCLM.2003.219
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Moderate hyperhomocysteinemia has been identified as a new independent risk factor for cardiovascular and neurodegenerative diseases. This fact has produced interest in the study of genetic variants involved in homocysteine metabolism and its relationship to pathogenesis. Recently, more than 15 different genes were studied for their relationship to plasma homocysteine levels. We determined the influence of genetic variants in five genes (5,10-methylenetetrahydrofolate reductase (MTHFR) 677C > T, serine hydroxymethyltransferase (SHMT) 1420C >T, thymidylate synthase (TS) 2R > 3R, catecholOmethyltransferase (COMT) 1947G --> A and transcobalamin (TC) 776C --> G) on plasma homocysteine, folic acid and parameters of vitamin B-12 metabolism in 111 vegetarians (mean age: 46+/-15 years) and 118 healthy seniors (mean age: 82+/-6.5 years). Median homocysteine concentration in plasma was significantly influenced by the MTHFR genotypes in both populations. In the vegetarians the median homocysteine level was increased by 8 mol/l in individuals homozygous for the mutation as compared to wildtype or heterozygous genotypes (20.4 mumol/l vs. 12.9 and 12.7 mumol/l, respectively). This unexpected increase was observed although the folate levels were in medium to elevated ranges. Our results suggest that vegetarians have a higher demand for folate to neutralize the genotype effect. Preclinical vitamin B-12 deficiency in vegetarians may be the cause for disturbed remethylation and folate trap. Plasma homocysteine was not significantly influenced by the SHMT, TS, COMT and TC mutations. In addition, for the TC mutation a trend toward cellular vitamin B-12 deficiency was observed. The methylmalonic acid (MMA) levels were slightly elevated and the holotranscobalaminII (holoTCII) levels decreased. In the vegetarian group a significant relationship between the COMT genotype and holoTCII concentration in plasma was determined, whereas the high activity COMT genotype (G/G) resulted in increased levels (35 mol/l vs. 21 mol/l for heterozygous and low activity genotypes). The MMA levels were inversely correlated to holoTCII concentrations. In conclusion, the study on vegetarians and seniors documents interesting lifestylegenotype interactions. Although the TC and COMT mutations influence cellular vitamin B-12 metabolism, this effect did not result in overt homocysteine elevation.
引用
收藏
页码:1427 / 1434
页数:8
相关论文
共 29 条
[1]   ELEVATION OF 2-METHYLCITRIC ACID-I AND ACID-II LEVELS IN SERUM, URINE, AND CEREBROSPINAL-FLUID OF PATIENTS WITH COBALAMIN DEFICIENCY [J].
ALLEN, RH ;
STABLER, SP ;
SAVAGE, DG ;
LINDENBAUM, J .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1993, 42 (08) :978-988
[2]   A polymorphism (80G->A) in the reduced folate carrier gene and its associations with folate status and homocysteinemia [J].
Chango, A ;
Emery-Fillon, N ;
de Courcy, GP ;
Lambert, D ;
Pfister, M ;
Rosenblatt, DS ;
Nicolas, JP .
MOLECULAR GENETICS AND METABOLISM, 2000, 70 (04) :310-315
[3]   Population variation in linkage disequilibrium across the COMT gene considering promoter region and coding region variation [J].
DeMille, MMC ;
Kidd, JR ;
Ruggeri, V ;
Palmatier, MA ;
Goldman, D ;
Odunsi, A ;
Okonofua, F ;
Grigorenko, E ;
Schulz, LO ;
Bonne-Tamir, B ;
Lu, RB ;
Parnas, J ;
Pakstis, AJ ;
Kidd, KK .
HUMAN GENETICS, 2002, 111 (06) :521-537
[4]   Glutamate carboxypeptidase II: a polymorphism associated with lower levels of serum folate and hyperhomocysteinemia [J].
Devlin, AM ;
Ling, EH ;
Peerson, JM ;
Fernando, S ;
Clarke, R ;
Smith, AD ;
Halsted, CH .
HUMAN MOLECULAR GENETICS, 2000, 9 (19) :2837-2844
[5]   A CANDIDATE GENETIC RISK FACTOR FOR VASCULAR-DISEASE - A COMMON MUTATION IN METHYLENETETRAHYDROFOLATE REDUCTASE [J].
FROSST, P ;
BLOM, HJ ;
MILOS, R ;
GOYETTE, P ;
SHEPPARD, CA ;
MATTHEWS, RG ;
BOERS, GJH ;
DENHEIJER, M ;
KLUIJTMANS, LAJ ;
VANDENHEUVEL, LP ;
ROZEN, R .
NATURE GENETICS, 1995, 10 (01) :111-113
[6]   Genetic defects as important factors for moderate hyperhomocysteinemia [J].
Geisel, J ;
Zimbelmann, I ;
Schorr, H ;
Knapp, JP ;
Bodis, M ;
Hübner, U ;
Herrmann, W .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2001, 39 (08) :698-704
[7]   Betaine-homocysteine methyltransferase (BHMT): Genomic sequencing and relevance to hyperhomocysteinemia and vascular disease in humans [J].
Heil, SG ;
Lievers, KJA ;
Boers, GH ;
Verhoef, P ;
den Heijer, M ;
Trijbels, FJM ;
Blom, HJ .
MOLECULAR GENETICS AND METABOLISM, 2000, 71 (03) :511-519
[8]   Is mutated serine hydroxymethyltransferase (SHMT) involved in the etiology of neural tube defects? [J].
Heil, SG ;
Van der Put, NMJ ;
Waas, ET ;
den Heijer, M ;
Trijbels, FJM ;
Blom, HJ .
MOLECULAR GENETICS AND METABOLISM, 2001, 73 (02) :164-172
[9]   Vitamin B-12 status, particularly holotranscobalamin II and methylmalonic acid concentrations, and hyperhomocysteinemia in vegetarians [J].
Herrmann, W ;
Schorr, H ;
Obeid, R ;
Geisel, J .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2003, 78 (01) :131-136
[10]   Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism and the B-vitamins: A facet of nature-nurture interplay [J].
Herrmann, W ;
Obeid, R ;
Schorr, H ;
Zarzour, W ;
Geisel, J .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2003, 41 (04) :547-553